click below
click below
Normal Size Small Size show me how
Drugs!
| Question | Answer |
|---|---|
| Prostaglandin E1 MOA | stim adenylyl cyclase, inc cAMP, relax VSM |
| Prostaglandin E1 use | treat heart defects in infants, ED |
| Milrinone MOA | PDE inhibitor, slows cAMP degradation |
| Milrinone use | Treat Failure |
| Nitroglycerine MOA | inc NO production- VSM relaxation |
| Nitroglycerine use | Treat angina, CHF, MI |
| Nitroglycerine adverse | Hypotension, contraindicated with viagra |
| Furosemide class | Diuretic (loop diuretic)- most effective |
| Furosemide use | hypertension, edema, CHF, renal failure symptoms |
| Diuretic adverse Rxn | Electrolyte disturbance |
| Acetazolamide | Diuretic (Carbonic Anhydrase Inhibitor) |
| Acetazolamide use | Hypertension, edema, CHF, renal failure symptoms |
| Hydrochlorothiazide class | Diuretic |
| Hydrochlorothiazide use | hypertension, edema, CHF, renal failure symptoms |
| Cardioactive antihypertensives | lower BP- Tx hypertension and heart failure |
| Cardioactive antihypertensive drugs | B blockers, Ca channel blockers |
| Isoproterenol | B1/B2 agonist |
| B1 agonist action | inc. cAMP, activate Ca channels- Ca influx |
| B2 agonist action | inc. cAMP, phospholamban activation, stim SERCA- Ca sequestration |
| B1 agonist use | tx. cardiogenic shock, heart failure |
| B2 agonist use | tx. asthma, emphysema |
| Dopamine MOA | dose dependent |
| low dose dopamine | dopamine receptor agonist |
| high dose dompamine | conversion to NE- a-receptor agonist |
| dopamine receptor agonist | vasodilation in renal system |
| Methotrexate MOA | dihydrofolate reductase competitive inhibitor |
| Methotrexate use | tx. cancer, autoimmune disease |
| Digoxin class | cardiac glycoside |
| Digoxin MOA | Inh. Na/Ca exchange (dec. Ca efflux), inh. Na/K ATPase (decreases gradient) |
| Digoxin use | Tx. heart failure |
| Digoxin adverse | dec. QT interva., inc. PR interval, ST depression |
| Propranolol class | Non-Selective B-antag |
| Propranolol use | Hypertension |
| B-blocker adverse | dec. exercise tolerance, bradycardia, conduction probs in heart |
| B-blocker contraindication | Heart failure |
| Acebutolol | Cardioselective B1 with ISA |
| Atenolol | Cardioselective B1 without ISA |
| Propranolol | Non-cardioselective B1/B2 without ISA |
| Pindolol | Non-cardioselective B1/B2 with ISA |
| Norepinephrine | A1 receptor agonist |
| Norepinephrine MOA | Gq activation- sm muscle contrxn |
| Norepinephrine effect | vasoconstrictor |
| Norepinephrine use | Tx. hypotension, nasal congestion |
| Clonidine class | Sympatholytic |
| Clonidine MOA | A2 agonist- inhibit vasomotor center in medulla oblongata, dec. symp activity |
| Clonidine use | tx. hypertension |
| Clonidine adverse | Can constrict coronaries (post-synaptic response) |
| Prazosin class | A1 antagonist |
| Prazosin MOA | Reduces NE/Epi binding, causing vasodilation |
| Prazosin use | tx. hypertension |
| Prazosin adverse | orthostatic hypertension |
| Captopril | ACE Inhibitor |
| Captopril MOA | Reduce Ang conversion, inhibit bradykinin degradation- vasodilation |
| Captopril use | hypertension, CHF, MI |
| Captopril adverse | Renal failure with art stenosis, bradykinin in lungs |
| Losartan class | Ang II Receptor Blocker |
| Losartan use | hypertension, CHF |
| Losartan adverse | renal failure with art stenosis |
| Nifedipine | Ca channel blocker |
| Nifedipine use | hypertension, vasospastic angina, arrhythmia |
| Nifedipine adverse | depress heart function |
| Acetominophen MOA | Inhibits COX 1 and 2- increases pain threshold and reduces fever |
| Acetominophen use | pain/fever |
| Prednisone MOA | inhibits phospholipase A2, red. inflammation |
| Prednisone use | inflammation, autoimmune disease |
| Nitroglycerine class | nitrate vasodilator |
| Nitrate MOA | inc. No production, inactivate MLCK- VSM relaxation |
| Nitrate use | angina, CHF, MI |
| Sumatriptan MOA | stim presynaptic receptors, inhibiting dural vasodilation and inflammation |
| Sumatriptan uses | Migraines/headaches |
| Nifedipine subclass | Dihydropyridine- Ca blocker |
| Verapamil | Phenylalkylamine subclass of Ca blockers |
| Verapamil | Affects heart more than BVs |
| Verapamil | potent neg chronotrope, inotrope, and dromotrope |
| Dilitiazem | Benzothiazepine subclass of Ca channel blockers |
| Dilitiazem | affects heart and BVs |
| Levosimendan | Ca Sensitizer |
| Levosimendan MOA | Inc Sens of cardiac troponin to Ca |
| Levosimendan MOA | Ca sens + PDE III inhibition- vasodilation |
| Levosimendan use | Heart failure |
| Levosimendan adverse | Hypotension and reflex tachycardia |
| Isocarboxazid | MAOI- affects NE metabolism |
| Isocarboxazid use | depression |
| Tolcapone | COMT inhibitor- affects NE metabolism |
| Tolcapone use | Parkinsons |
| Mecamylamine | Nicotinic antagonist |
| Mecamylamine | reduce BP |
| Mecamylamine use | Surgical BP control |
| Demecarium Ambenonium | Indirect cholinergic agonist (AChE inhibitor) |
| Demecarium use | open angle glaucoma, myasthenia gravis |
| Pilocarpine | Cholinomimetic- muscarinic agonist |
| Pilocarpine use | ocular hypertension, open and closed angle glaucoma |
| Tolterodine | Anticholinergic- muscarinic antagonist |
| Tolterodine use | Overactive bladder |
| Atropine | Anticholinergic- muscarinic antagonist |
| Atropine use | reduce airway secretions during intubation |
| Amphetamine | Affects NE release |
| Amphetamine use | ADHD |
| Desipramine | Affects NE Reuptake |
| Desipramine use | depression |
| Reserpine | Affects Vesicular packaging of NE |
| Reserpine use | hypertension |
| Metyrosine | affects NE synthesis |
| Metyrosine use | tx pheocromacytoma |
| B antagonist without ISA | full antagonists |
| atenolol, metoprolol | B1 (cardioselective) antagonists |
| Carvedilol, Labetolol, Nadolol, Propranolol | B1/B2 (noncardioselective) antagonist |
| B-Antagonists with ISA | Act as partial agonists |
| Acebutolol | Cardioselective B1 |
| Penbutolol, Careolol, Pindolol | Non-cardioselective B1/B2 |
| Terbutaline | B2 Agonist |
| Terbutaline uses | asthma, emphysema (relaxes airways) |
| Dobutamine | B1 agonist |
| Dobutamine use | Tx. Cardiac decomposition |
| Metoprolol | B1 antagonist |
| Metoprolol use | tx. hypertension |
| Yohimbine | A2 antagonist |
| Yohimbine use | Tx ED (injection), produce miosis |
| Phenylephrine | A1 agonist |
| Phenylephrine use | tx. hypotension, congestion |
| A1 receptor | high affinity for Epi |
| A2 receptor | high affinity for epinephrine |
| B1 receptor | high affinity for Isoproteronol |
| B2 receptor | high affinity for Isoproteronol |
| M2 Receptor signaling | Gi/G0- hyperpolarization and inhibition |
| M3 Receptor signaling | Gq- depolarization and excitation |
| B2 Receptor signaling | Gs- inc. adenylyl cyclase |
| A1 Receptor signaling | Gq- depolarization and excitation, Gi/0- inc PLA2 |
| B1 Receptor signaling | Gs- incl adenylyl cyclase |
| A2 Receptor signaling | Gi- dec. adenylyl cyclase, G0- inh. Ca channels, inc PLC and PLA2 |